Lantheus Holdings Inc (LNTH) Short Interest Down 64.7% in December
Lantheus Holdings Inc (NASDAQ:LNTH) was the target of a significant drop in short interest in the month of December. As of December 29th, there was short interest totalling 468,011 shares, a drop of 64.7% from the December 15th total of 1,324,332 shares. Based on an average trading volume of 303,775 shares, the days-to-cover ratio is currently 1.5 days. Approximately 1.3% of the shares of the stock are sold short.
Shares of Lantheus (LNTH) opened at $22.15 on Wednesday. Lantheus has a twelve month low of $7.95 and a twelve month high of $24.10. The company has a debt-to-equity ratio of -3.41, a current ratio of 2.96 and a quick ratio of 2.46. The stock has a market capitalization of $880.45, a PE ratio of 27.35, a PEG ratio of 1.52 and a beta of 0.94.
Lantheus (NASDAQ:LNTH) last issued its earnings results on Thursday, November 2nd. The medical equipment provider reported $0.24 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.20 by $0.04. Lantheus had a negative return on equity of 46.45% and a net margin of 9.59%. The firm had revenue of $79.94 million for the quarter, compared to analysts’ expectations of $77.18 million. During the same period in the previous year, the firm posted $0.15 earnings per share. The business’s revenue was up 9.4% compared to the same quarter last year. research analysts anticipate that Lantheus will post 1.05 EPS for the current fiscal year.
In other Lantheus news, insider Michael P. Duffy sold 21,655 shares of the firm’s stock in a transaction dated Wednesday, January 10th. The stock was sold at an average price of $22.40, for a total transaction of $485,072.00. Following the sale, the insider now directly owns 156,784 shares of the company’s stock, valued at $3,511,961.60. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Timothy G. Healey sold 11,314 shares of the firm’s stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $21.51, for a total value of $243,364.14. The disclosure for this sale can be found here. Over the last three months, insiders have sold 44,886 shares of company stock worth $986,201. Insiders own 2.30% of the company’s stock.
Hedge funds have recently modified their holdings of the company. Quantbot Technologies LP bought a new stake in shares of Lantheus in the second quarter worth about $117,000. Sei Investments Co. increased its holdings in shares of Lantheus by 189.6% in the third quarter. Sei Investments Co. now owns 7,829 shares of the medical equipment provider’s stock worth $139,000 after purchasing an additional 5,126 shares during the last quarter. Bank of Montreal Can increased its holdings in shares of Lantheus by 371.6% in the fourth quarter. Bank of Montreal Can now owns 6,819 shares of the medical equipment provider’s stock worth $139,000 after purchasing an additional 5,373 shares during the last quarter. Teachers Retirement System of The State of Kentucky bought a new stake in Lantheus during the second quarter worth approximately $141,000. Finally, BNP Paribas Arbitrage SA bought a new stake in Lantheus during the second quarter worth approximately $146,000. 91.91% of the stock is currently owned by hedge funds and other institutional investors.
WARNING: “Lantheus Holdings Inc (LNTH) Short Interest Down 64.7% in December” was published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this article on another publication, it was stolen and reposted in violation of United States & international copyright laws. The correct version of this article can be viewed at https://theolympiareport.com/2018/01/17/lantheus-holdings-inc-lnth-short-interest-down-64-7-in-december.html.
Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.
Receive News & Ratings for Lantheus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus and related companies with MarketBeat.com's FREE daily email newsletter.